ClinicalTrials.gg
Status unknownNCT01333683Updated Mar 6, 2015

Tinnitus and Arterial Hypertension

An observational study in Tinnitus, Hearing Loss and Arterial Hypertension, sponsored by Faculdade de Medicina de Valenca. Status unknown at 1 site in Brazil. Open to participants aged 40 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-06.

Sponsored by Faculdade de Medicina de Valenca · Observational

The sponsor has not verified this record recently (last verified Mar 2015), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
40 Years to 49 Years
Sex
All
01

Study summary

Many authors link tinnitus to arterial hypertension. The aim of this study is to establish a possible relationship between them, analyze the severity of tinnitus related to arterial hypertension and analyze a possible influence of ototoxic drugs used to treat arterial hypertension

Read the detailed description

Arterial hypertension has been cited as a possible tinnitus etiology. Vascular abnormalities associated with it may account for cochlear and central nervous system. However, a relationship between tinnitus and arterial hypertension has never been established. The aim of this study is to analyze this relationship, comparing groups with and without arterial hypertension and the incidence of tinnitus amongst them. Inclusion and exclusion criteria try to isolate arterial hypertension as the main etiological factor, as much as possible. Presbycusis, noise exposure, metabolical diseases and genetic factors will be ruled out. A comparison will be performed inside the arterial hypertension group between subgroups that use or not ototoxic medications, such as furosemide and beta-blockers

02

Conditions studied

  • Tinnitus
  • Hearing Loss
  • Arterial Hypertension

Keywords

  • tinnitus
  • hearing loss
  • arterial hypertension
  • ototoxicity
03

In context

Tinnitus

421 studies on the registry are indexed under Tinnitus; 88 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 55 observational studies indexed under Tinnitus.

Browse Tinnitus studies →

Lead sponsor

Faculdade de Medicina de Valenca is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 49 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients agedd between 40 and 50

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age between 40 and 50
  • arterial hypertension for group 1
  • at least 5 years standing arterial hypertension

Exclusion criteria

Exclusion Criteria:

  • chronic noise exposure
  • metabolic diseases
  • family antecedents of hearing loss (except for presbycusis)
  • pregnant women
  • use of ototoxic drugs (except for anti-hypertensives)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)

Groups and cohorts

  • Control

    Normal subjects

  • AH

    Arterial hypertension patients

06

What researchers measure

Primary outcomes

  1. Incidence of tinnitus - have tinnitus x don't have tinnitus

    The purpose of this study is to compare tinnitus incidence between patients with and without arterial hypertension.

    Time frame: Up to 6 months

Secondary outcomes

  1. Severity of tinnitus - Tinnitus Handicap Inventory

    Severity of tinnitus measured by Tinnitus Handicap Inventory, to evaluate differences between patients with and without arterial hypertension

    Time frame: Up to 6 months

07

Study locations

1 site
  • Faculdade de Medicina de Valença
    Valença, Rio de Janeiro 27660-000, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01333683
Lead sponsor
Faculdade de Medicina de Valenca
Responsible party
Ricardo Rodrigues Figueiredo (M.D, MSc, Faculdade de Medicina de Valenca) — Principal investigator
First posted
Apr 12, 2011
Start date
Apr 2011
Primary completion
Apr 2015 (estimated)
Completion
Oct 2015 (estimated)
Last update
Mar 6, 2015

Study contacts

Ricardo R Figueiredo, MD,MSc
principal investigator · Otosul, Valença Medical School

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion